Searched for
STRIDES ARCOLABS
- Buy Strides Arcolab Ltd with a target of Rs 1425: Mitesh Thacker"Strides Arcolab Ltd is a 'BUY' call with a target of Rs 1425 and a stop loss of Rs 1342."
Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...- Buy Strides Arcolab with a target of Rs 1,060: Ashwani Gujral'Buy Strides Arcolab with a target of Rs 1,010 and a stop loss of Rs 960'
- Sell Strides Arcolab with a stop loss of Rs 883: Mitesh ThackerStrides Arcolab Ltd is a 'SELL' call with a target of Rs 825 and a stop loss of Rs 883.
- Buy Strides Arcolab with a target of Rs 1050: Ashwani GujralStrides Arcolab is a 'BUY' call with a target of Rs 1050.
- Buy Strides Arcolab with a target of Rs 950: Mitesh Thacker"Strides Arcolab is a 'BUY' call with a target of Rs 950 and a stop loss of Rs 904."
- Buy Strides Arcolab Ltd with target of Rs 950: Ashwani GujralStrides Arcolab Ltd is a 'BUY' call with a target of Rs 950 and a stop loss of Rs 885.
- Buy Strides Arcolab Ltd with a target of Rs 985: Mitesh Thacker"Strides Arcolab Ltd is a ‘BUY’ call with a target of Rs 985 and a stop loss of Rs 919."
- Buy Strides Arcolab Ltd with a target of Rs 980: Sandeep Wagle"Strides Arcolab Ltd is a 'BUY' call with a target of Rs 980 and a stop loss of Rs 920."
- Buy Strides Arcolab with a target of Rs 1020: Prakash Gaba'Strides Arcolab is a 'BUY' call with a target of Rs 1020 and a stop loss of Rs 934.
- Buy Strides Arcolab with a target of Rs 810: Prakash Gaba"Strides Arcolab is 'Buy' call with a target of Rs 810 and a stop loss of Rs 785."
- Strides Arcolab invests in Oncobiologics Inc, acquires stakeShares of Strides Arcolab were today trading at Rs 667.60 per scrip in the morning trade on BSE, up 2.54 per cent from its previous close.
- Buy Strides Arcolab with a target of Rs 600: Ashwani Gujral"Strides Arcolab Ltd is a 'BUY' call with a target of Rs 600 and a stop loss of Rs 530"
- Goldman Sachs sells Strides Arcolab shares for Rs 33.4 croreGoldman Sachs Investments Mauritius today sold 3.80 lakh shares of drug major Strides Arcolab for nearly Rs 33.4 crore in open market.
- Financial services firms buy Strides Arcolab scrips worth Rs 66 crBNP Paribas Arbitrage purchased 5.03 lakh shares of Strides Arcolab for an estimated Rs 38.21 crore, as per information available with the ...
- Morgan Stanley sells shares of Strides Arcolab for Rs 33 crThe shares were offloaded at an average price of Rs 900 apiece, according to the bulk deal data available with stock exchanges.
- Buy Strides Arcolab with a target of 900: Prakash GabaStrides Arcolab Ltd is a ‘BUY’ call with a target of Rs 900 and a stop loss of Rs 845.
- Strides Arcolab gets USFDA nod for cancer injectionDrug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...
- Strides Arcolab gets USFDA nod for Bangalore unit's productDrug firm Strides Arcolab today said it has received US health regulator's approval to market a product from its new facility in Karnataka.
- Strides Arcolab tends to do well in spurts: Ashwani Gujral, Market StrategistStrides Arcolab needs to cross levels of 399-400 before it can get back into that range of about 400-460.
Load More- Sell Strides Arcolab with a stop loss of Rs 883: Mitesh Thacker
